Published in Lab Law Weekly, February 16th, 2007
The funding of the programme was made by ITI Life Sciences.
"This is an immensely exciting programme, and we are very much looking forward to participating in it. This important collaboration is in line with our strategic goal of scaling up our human embryonic stem cell technology," commented Mats Lundwall, CEO of Cellartis.
"Life science research in Scotland, particularly in the stem cell area, is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly